The present invention relates, in general, to human immunodeficiency virus (HIV) and, in particular, to an HLA-based HIV vaccine.

 
Web www.patentalert.com

< Gp120 mutants and biological applications

< Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit I

> DNA vaccines for farm animals, in particular bovines and porcines

> Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
~ 00276